Concepedia

Jessica C. Hassel

JC

Statistics

Publications

179

Citations

49K

H-Index

59

Active since

2004

Affiliations

Heidelberg University(Current)

University Hospital Heidelberg

National Center for Tumor Diseases

German Cancer Research Center

Medizinische Hochschule Hannover

Jessica C. Hassel is an author at Heidelberg University specializing in medicine, oncology, and immunology.

ORCID

Top concepts

Publications per year

2004–2024

179

Publications

179

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi, Steven O’Day, David F. McDermott et al. · New England Journal of Medicine · 2010 · 14.9K citations · Full text

Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation

Caroline Robert, Georgina V. Long, Benjamin Brady et al. · New England Journal of Medicine · 2014 · 5.3K citations · Full text

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

Eliezer M. Van Allen, Diana Miao, Bastian Schilling et al. · Science · 2015 · 2.9K citations · Full text

, , +14

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial

Jeffrey S. Weber, Sandra P. D’Angelo, David R. Minor et al. · The Lancet Oncology · 2015 · 2.6K citations

, , +9

Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma

Keith T. Flaherty, Caroline Robert, Peter Hersey et al. · New England Journal of Medicine · 2012 · 2.1K citations · Full text

1–5 of 179